J. Engele, SPATIAL AND TEMPORAL GROWTH-FACTOR INFLUENCES ON DEVELOPING MIDBRAIN DOPAMINERGIC-NEURONS, Journal of neuroscience research, 53(4), 1998, pp. 405-414
Despite the large number of growth factors shown to affect dopaminergi
c cell survival and differentiation in vitro, presently little is know
n about the role these growth factors play during normal in vivo devel
opment of dopaminergic neurons. To address this issue, glia and neuron
s of both the mesencephalic home region as well as the striatal and co
rtical target areas have been screened for effects on dopaminergic cel
l survival in serum-free dissociated cell cultures of the embryonic da
y (E) 15 and E17 rat mesencephalon. In E15 mesencephalic cultures, the
number of surviving tyrosine hydroxylase-immunoreactive dopaminergic
neurons maximally increased 2.6-fold with medium conditioned by glia o
f the E15-E20 mesencephalon, the E17-E20 striatum, or the E20 cortex.
In marked contrast, all glial-conditioned media (CM) failed to affect
dopaminergic cell survival in E17 mesencephalic cultures. Similarly, E
17 dopaminergic cell survival was not affected by CM derived from stri
atal or mesencephalic neurons. This absence of survival-promoting effe
cts was not due to a general lack of sensitivity of the late embryonic
dopaminergic neurons to growth factors. Basal survival of cultured E1
7 dopaminergic neurons declined with PD98059 (20 mu M), a potent inhib
itor of growth factor-activated microtubule-associated protein (MAP) k
inase cascade. Moreover, irrespective of the age of the cultured mesen
cephalic tissue, dopaminergic growth factors with potential autocrine
functions such as brain-derived neurotrophic factor (BDNF; 50 ng/ml) a
nd glial cell line-derived neurotrophic factor (GDNF; 10 ng/ml) promot
ed dopaminergic cell survival 1.5- to 1.9-fold. These findings suggest
that dopaminergic cell survival is predominantly affected by, as yet
unknown, growth factors derived from mesencephalic, cortical, and stri
atal glia during early embryonic development, and by autocrine-acting
growth factors during late development stages. (C) 1998 Wiley-Liss,Inc
.